Literature DB >> 32723097

The world of cell penetrating: the future of medical applications.

Annarita Falanga1, Lucia Lombardi2, Emilia Galdiero3, Valentina Del Genio2, Stefania Galdiero2.   

Abstract

Cell-penetrating peptides present huge biomedical applications in a variety of pathologies, thanks to their ability to penetrate membranes and carry a variety of cargoes inside cells. Progress in peptide synthesis has produced a greater availability of virtually any synthetic peptide, increasing their attractiveness. Most molecules when associated to a cell-penetrating peptides can be delivered into a cell, however, understanding of the critical factors influencing the uptake mechanism is of paramount importance to construct nanoplatforms for effective delivery in vitro and in vivo in medical applications. Focus is now on the state-of-art of the mechanisms enabling therapeutics/diagnostics to reach the site target of their activities, and in support of scientists developing platforms for drug delivery and personalized therapies.

Keywords:  cell-penetrating peptide; drug delivery; nanomedicine

Mesh:

Substances:

Year:  2020        PMID: 32723097     DOI: 10.4155/fmc-2020-0140

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  8 in total

1.  Cell-Penetrating Peptides.

Authors:  Matjaž Zorko; Ülo Langel
Journal:  Methods Mol Biol       Date:  2022

2.  Design and use of chimeric peptides in a new non-destructive ecological process applied to the extraction of all trans/9-cis β-carotene isomers from Dunaliella salina.

Authors:  Soumaya Kouidhi; Wissem Mnif; Nada Alqarni; Soukaina Abdelwahed; Alaeddine Redissi; Nihel Ammous; Boulbaba Selmi; Ali Gargouri; Sami Achour; Ameur Cherif; Amor Mosbah
Journal:  Food Sci Nutr       Date:  2022-03-14       Impact factor: 3.553

3.  Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy.

Authors:  Rúben Faria; Milan Paul; Swati Biswas; Eric Vivès; Prisca Boisguérin; Ângela Sousa; Diana Costa
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

4.  Salmon Protein Hydrolysate Potentiates the Growth Inhibitory Effect of Bicalutamide on Human Prostate Cancer Cell Lines LNCaP and PC3 by Modulating Iron Homeostasis.

Authors:  Christian Bjerknes; Bomi Framroze; Crawford Currie; Caroline Hild Hakvåg Pettersen; Karol Axcrona; Erland Hermansen
Journal:  Mar Drugs       Date:  2022-03-28       Impact factor: 6.085

5.  Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors.

Authors:  Anselm F L Schneider; Joerg Kallen; Johannes Ottl; Patrick C Reid; Sebastien Ripoche; Stephan Ruetz; Therese-Marie Stachyra; Samuel Hintermann; Christoph E Dumelin; Christian P R Hackenberger; Andreas L Marzinzik
Journal:  RSC Chem Biol       Date:  2021-08-26

Review 6.  Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies.

Authors:  Valentina Del Genio; Rosa Bellavita; Annarita Falanga; Katel Hervé-Aubert; Igor Chourpa; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

7.  Cyclic Peptoid-Peptide Hybrids as Versatile Molecular Transporters.

Authors:  Claudine Nicole Herlan; Anna Meschkov; Ute Schepers; Stefan Bräse
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

8.  Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide.

Authors:  Yu Du; Xinrui Lin; Qiang Feng; Xinyan Pan; Shuling Song; Julun Yang
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.